Navigation Links
steadylite plus Reporter Gene Assay System, 100 mL from PerkinElmer

Productssteadylite plus Reporter Gene Assay System, 100 mL from PerkinElmer
Company PerkinElmer
Item steadylite plus Reporter Gene Assay System, 100 mL
Price $543.00
Description The steadylite plus assay system offers the following benefits: High assay sensitivity, Designed for batch-processing systems, Long lasting signal, Suitable for higher density microplates such as 384-well and 1536-well plates, Odor free, Convenient storage conditions ( 2 - 8 C)
Info PerkinElmerPerkinElmer
PerkinElmer Life & Analytical Sciences.
710 Bridgeport Avenue
Shelton, CT 06484-4794, USA





Call PerkinElmer to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-823-5510
Customer Service: (800) 762-4000; Outside the USA: (+1) 203-925-4602
Fax Number: (203) 944-4904
Web Site: http://www.perkinelmer.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. steadylite plus Reporter Gene Assay System, 1000 mL from PerkinElmer
2. Luciferase Reporter Assay Kit from MBL International
3. Glutathione-S-Transferase (GST) Colorimetric Assay Kit from Sigma-Aldrich
4. In Vitro Osteogenesis Assay Kit from CHEMICON
5. Mast Cell Degranulation colorimetric Assay Kit from CHEMICON
6. PR Competitor Assay Green from Invitrogen
7. PolarScreen Androgen Receptor Competitor Assay Kit, Red from Molecular Probes (Invitrogen)
8. Hydrogen Peroxide / Peroxidase Fluorometric (resorufin) Assay Kit, Fluoro H2O2 from BACHEM
9. PPARGamma-Competitor Assay Kit Green from Invitrogen
10. Total antioxidant capacity Colorimetric Assay Kit from Neogen Corporation
11. PolarScreen Progesterone Receptor Competitor Assay Kit, Far Red from Molecular Probes (Invitrogen)
Breaking Biology Technology:YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 2Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 2Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 3